Hospital admission among HIV-exposed uninfected children compared with HIV-unexposed children

Ellen Moseholm1, Marie Helleberg, Sannie B Nordly

  • 1aDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre bDepartment of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet cDepartment of Pediatrics, Copenhagen University Hospital, Hvidovre dDepartment of Infectious Diseases, Aarhus University Hospital, Skejby eDepartment of Infectious Diseases, Aalborg University Hospital fDepartment of Infectious Diseases, Odense University Hospital gDepartment of Pulmonary and Infectious Diseases, Copenhagen University Hospital, Nordsjælland, Denmark.

AIDS (London, England)
|August 19, 2016
PubMed

Insights

HIV-exposed uninfected (HEU) children show a higher risk of hospital admissions, primarily for observation/nonspecific diagnoses, not infectious diseases. This increased admission risk may stem from monitoring and testing rather than direct HIV-related illness.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Children born to mothers with HIV (HIV-exposed uninfected - HEU) may face unique health challenges.
  • Understanding health outcomes in HEU children is crucial for targeted interventions and care.
  • Previous studies suggest potential differences in health outcomes for HEU populations.

Purpose of the Study:

  • To investigate the risk of hospital admissions and antibiotic use in HEU children.
  • To compare these outcomes in HEU children against a matched cohort of HIV-unexposed children.
  • To analyze specific reasons for hospital admissions in HEU children up to four years of age.

Main Methods:

  • A nationwide register-based cohort study design was employed.
  • HIV-exposed uninfected (HEU) children born in Denmark (2000-2012) were matched with HIV-unexposed controls.
  • Poisson regression analysis was used to estimate incidence rate ratios (IRRs) for hospital admissions and antibiotic use.

Main Results:

  • HIV-exposed uninfected (HEU) children exhibited a threefold increased risk of overall hospital admissions (IRR 3.49).
  • No significant difference was observed in admissions due to infectious diseases (IRR 1.11) or antibiotic use (IRR 0.88).
  • The excess admissions were predominantly linked to observation/nonspecific diagnoses (IRR 6.06).

Conclusions:

  • HIV-exposed uninfected (HEU) children face an elevated risk of overall hospital admission, mainly for observation/nonspecific diagnoses.
  • The study found no increased risk of admissions for infectious diseases or higher antibiotic use in HEU children.
  • The heightened admission risk in HEU children may be associated with prophylactic treatments and HIV testing protocols, not direct HIV-related health issues.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K